These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35483554)

  • 1. Development of a smartphone-based quantum dot lateral flow immunoassay strip for ultrasensitive detection of anti-SARS-CoV-2 IgG and neutralizing antibodies.
    Li J; Liu B; Tang X; Wu Z; Lu J; Liang C; Hou S; Zhang L; Li T; Zhao W; Fu Y; Ke Y; Li C
    Int J Infect Dis; 2022 Aug; 121():58-65. PubMed ID: 35483554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a quantum dot-based lateral flow immunoassay strip for rapid and sensitive detection of SARS-CoV-2 neutralizing antibodies.
    Wang X; Shao S; Ye H; Li S; Gu B; Tang B
    Sci Rep; 2023 Dec; 13(1):22253. PubMed ID: 38097611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive and Simultaneous Detection of SARS-CoV-2-Specific IgM/IgG Using Lateral Flow Immunoassay Based on Dual-Mode Quantum Dot Nanobeads.
    Wang C; Yang X; Gu B; Liu H; Zhou Z; Shi L; Cheng X; Wang S
    Anal Chem; 2020 Dec; 92(23):15542-15549. PubMed ID: 33207872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a quantitative lateral flow immunoassay (LFIA)-based point-of-care (POC) rapid test for SARS-CoV-2 neutralizing antibodies.
    Pieri M; Nicolai E; Nuccetelli M; Sarubbi S; Tomassetti F; Pelagalli M; Minieri M; Terrinoni A; Bernardini S
    Arch Virol; 2022 May; 167(5):1285-1291. PubMed ID: 35377034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latex Microsphere-Based Bicolor Immunochromatography for Qualitative Detection of Neutralizing Antibody against SARS-CoV-2.
    Liang Z; Peng T; Jiao X; Zhao Y; Xie J; Jiang Y; Meng B; Fang X; Yu X; Dai X
    Biosensors (Basel); 2022 Feb; 12(2):. PubMed ID: 35200362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of receptor binding domain-based double-antigen sandwich lateral flow immunoassay for the detection and evaluation of SARS-CoV-2 neutralizing antibody in clinical sera samples compared with the conventional virus neutralization test.
    Zhang Y; Chen Y; He Y; Li Y; Zhang X; Liang J; He J; Lu S; Gao Z; Xu J; Tang Y
    Talanta; 2023 Apr; 255():124200. PubMed ID: 36565525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of SARS-CoV-2 Neutralizing Antibodies in Vaccinated Pregnant Women and Neonates by Using a Lateral Flow Immunoassay Coupled with a Spectrum-Based Reader.
    Chen WC; Lin YP; Cheng CM; Shen CF; Li CW; Wang YK; Shih TY; Hong C; Chang TC; Shen CJ
    Biosensors (Basel); 2022 Oct; 12(10):. PubMed ID: 36291029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma.
    Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V
    J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasensitive and Simultaneous Detection of Two Specific SARS-CoV-2 Antigens in Human Specimens Using Direct/Enrichment Dual-Mode Fluorescence Lateral Flow Immunoassay.
    Wang C; Cheng X; Liu L; Zhang X; Yang X; Zheng S; Rong Z; Wang S
    ACS Appl Mater Interfaces; 2021 Sep; 13(34):40342-40353. PubMed ID: 34412466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technical performance of a lateral flow immunoassay for detection of anti-SARS-CoV-2 IgG in the outpatient follow-up of non-severe cases and at different times after vaccination: comparison with enzyme and chemiluminescent immunoassays.
    Barreira GA; Santos EHD; Pereira MFB; Rodrigues KA; Rocha MC; Kanunfre KA; Marques HHS; Okay TS; ; Eisencraft AP; Rossi Junior A; Fante AL; Cora AP; Costa Reis AGA; Ferrer APS; Andrade APM; Watanabe A; Gonçalves AMF; Waetge ARP; Silva CA; Ceneviva C; Lazari CDS; Abellan DM; Sabino EC; Bianchini FRM; Alcantara FFP; Ramos GF; Leal GN; Rodriguez IS; Pinho JRR; Carneiro JDA; Paz JA; Ferreira JC; Ferranti JF; Ferreira JOA; Framil JVS; Silva KRD; Bastos KLM; Galleti KV; Cristofani LM; Suzuki L; Campos LMA; Perondi MBM; Diniz MFR; Fonseca MFM; Cordon MNA; Pissolato M; Peres MS; Garanito MP; Imamura M; Dorna MB; Luglio M; Aikawa NE; Degaspare NV; Sakita NK; Udsen NL; Scudeller PG; Gaiolla PVV; Severini RDSG; Rodrigues RM; Toma RK; Paula RIC; Palmeira P; Forsait S; Farhat SCL; Sakano TMS; Koch VHK; Cobello Junior V
    Rev Inst Med Trop Sao Paulo; 2022; 64():e49. PubMed ID: 35858039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal profile of neutralizing and binding antibodies in vaccinated and convalescent COVID-19 cohorts by chemiluminescent immunoassays.
    Dou X; Wang E; Jiang R; Li M; Xiong D; Sun B; Zhang X
    Immun Inflamm Dis; 2022 Jun; 10(6):e612. PubMed ID: 35634960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.
    Valdivia A; Torres I; Latorre V; Francés-Gómez C; Albert E; Gozalbo-Rovira R; Alcaraz MJ; Buesa J; Rodríguez-Díaz J; Geller R; Navarro D
    Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):485-494. PubMed ID: 33404891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and multi-center clinical trials of an up-converting phosphor technology-based point-of-care (UPT-POCT) assay for rapid COVID-19 diagnosis and prediction of protective effects.
    Zhang P; Li B; Wang Y; Min W; Wang X; Zhou Y; Li Z; Zhao Y; Zhang H; Jiang M; Zheng H; Yang C; Zhang W; Zuo L; Gao Q; Yang Z; Li Y; Feng T; Lin C; Hu Q; Song T; Yang R
    BMC Microbiol; 2022 Feb; 22(1):42. PubMed ID: 35114938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
    Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
    J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The instantly blocking-based fluorescent immunochromatographic assay for the detection of SARS-CoV-2 neutralizing antibody.
    Li Y; He J; Zhang Y; Liang D; Zhang J; Ji R; Wu Y; Su Z; Ke C; Xu N; Tang Y; Xu J
    Front Cell Infect Microbiol; 2023; 13():1203625. PubMed ID: 37736103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the IgG antibody response to SARS CoV-2 infection and performance of a lateral flow immunoassay: cross-sectional and longitudinal analysis over 11 months.
    Robertson LJ; Moore JS; Blighe K; Ng KY; Quinn N; Jennings F; Warnock G; Sharpe P; Clarke M; Maguire K; Rainey S; Price RK; Burns WP; Kowalczyk AM; Awuah A; McNamee SE; Wallace GE; Hunter D; Sager S; Chao Shern C; Nesbit MA; McLaughlin JAD; Moore T
    BMJ Open; 2021 Jun; 11(6):e048142. PubMed ID: 34187827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort.
    Zhang S; Xu K; Li C; Zhou L; Kong X; Peng J; Zhu F; Bao C; Jin H; Gao Q; Zhao X; Zhu L
    Front Immunol; 2022; 13():829665. PubMed ID: 35154152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2).
    Lee JH; Choi M; Jung Y; Lee SK; Lee CS; Kim J; Kim J; Kim NH; Kim BT; Kim HG
    Biosens Bioelectron; 2021 Jan; 171():112715. PubMed ID: 33099241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.
    Kitagawa Y; Imai K; Matsuoka M; Fukada A; Kubota K; Sato M; Takada T; Noguchi S; Tarumoto N; Maesaki S; Takeuchi S; Maeda T
    J Med Virol; 2022 Jan; 94(1):335-341. PubMed ID: 34524695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.